- Record: found
- Abstract: found
- Article: not found
Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs.
Paul Emery
1 ,
Gaia Gallo ,
Helen Boyd ,
Christopher L Morgan ,
Craig J Currie ,
Christopher D Poole ,
Henk W Nab
September 6 2014
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine the risk of serious infection in patients with rheumatoid arthritis (RA) receiving etanercept (ETN) or disease-modifying anti-rheumatic drugs (DMARDs) and to identify factors that predict a higher risk.